• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Lundbeck simplifies and restructures, 200 jobs to be cut

Lundbeck simplifies and restructures, 200 jobs to be cut

September 30, 2013
CenterWatch Staff

Lundbeck, a global pharmaceutical company specialized in brain diseases, has simplified its commercial structure, increased alignment across countries and improved competencies and investments in market access as a result of its Fit-for-the-Future program.

Lundbeck's Fit-for-the-Future program was announced on June 20, with the aim to reduce complexity, increase organizational efficiency and free up resources to ensure our successful transition toward a sustainable new Lundbeck. The program includes initiatives to optimize and standardize administrative processes, reduce supply chain complexity, ensure more effective execution of clinical trials, structure procurement and decrease spending on less critical activities. This program follows the plan to divide the commercial operations into six regions: Europe, U.S., Canada, Asia, Latin America and Middle East and global distribution to reflect the global diversification of the company and ensures full focus on growth markets. The commercial structure in Europe, with its more than 30 affiliates, will be organized in 10 business units. The Fit-for-the Future program is expected to run through 2015. 

Anders Götzsche, executive vice president and chief financial officer at Lundbeck, said, "We are very aware that these initiatives affect many employees and we will strive to mitigate any negative effects these might have."

Earlier initiatives include the Decisions Now program and the optimizations of Lundbeck's R&D activities.

The full effect of this program is expected to deliver an annual benefit of more than $90 million from 2016. Lundbeck proposes to restructure its business services in Europe and establish a business service center in Poland. The restructuring is likely to impact approximately 180 to 200 positions in 2014 to 2015.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing